Immune response modifier compositions and methods
US10005772B2 · kind B2 · utility
4Cited by
80References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2007 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Aug 5, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA46B2200/104
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an immune response modifier (IRM) composition that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety, wherein the covalent link comprises a labile bond directly attached to the IRM moiety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.